Back to Orexin a research
orexin a 2025-03-25 ClinicalTrials

Accelerated Transcranial Magnetic Stimulation modes investigated for Treatment-Resistant Depression efficacy and safety.

Comparison of Different Acceleration Modes of Transcranial Magnetic Stimulation

Abstract

Efficacy and safety of 6x/day and 10x/day accelerated TMS vs. sham stimulation for Treatment-Resistant Depression are being compared.


orexin a
Source: clinicaltrials:NCT06881030 · Ingested Jun 26, 2026 · Digest: gemini-2.5-flash